Protein kinase C and amyloid precursor protein processing in skin fibroblasts from sporadic and familial Alzheimer's disease cases
- Monika Vestling,
- Ángel Cedazo-Mínguez,
- ,
- Birgitta Wiehager,
- Marco Racchi,
- Lars Lannfelt
- Karolinska Institutet,
- University of Milan
Open access
Abstract
Non-amyloidogenic α-secretase processing of amyloid precursor protein (APP) is stimulated by protein kinase C (PKC). Levels and activity of PKC are decreased in sporadic Alzheimer's disease skin fibroblasts. We investigated whether alterations in PKC and PKC-mediated APP processing occur also in fibroblasts established from individuals with familial Alzheimer's disease APP KM670/671NL, PS1 M146V and H163Y mutations. These pathogenic mutations are known to alter APP metabolism to increase Aβ. PKC activities, but not levels, were decreased by 50% in soluble fractions from sporadic Alzheimer's disease cases. In contrast, familial Alzheimer's disease fibroblasts showed no significant changes in PKC enzyme activity. Fibroblasts bearing the APP KM670/671NL mutation showed no significant differences in either PKC levels or PKC-mediated soluble APP (APPs) secretion, compared to controls. Fibroblasts bearing PS1 M146V and H163Y mutations showed a 30% increase in soluble PKC levels and a 40% decrease in PKC-mediated APPs secretion. These results indicate that PKC deficits are unlikely to contribute to increased Aβ seen with APP and PS1 mutations, and also that PS1 mutations decrease α-secretase derived APPs production independently of altered PKC activity. Copyright (C) 1999 Elsevier Science B.V.
Research Output Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages 341-350 (10 pages)Journal (Volume, Issue Number)
Biochimica et Biophysica Acta - Molecular Basis of Disease (Volume 1453, Issue 3)Publication milestones
- Published - 30/03/1999
Publication status
ISSN
0925-4439Publication IDs
- Scopus: 0344507324
- PubMed: 10101252
